Matteo Trucco
Case Comprehensive Cancer Center, Cleveland Clinic Foundation Taussig Cancer Institute · Cleveland Clinic Hospital · Cleveland Clinic, Case Comprehensive Cancer Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Matteo Trucco as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 01:24 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT07695311 · EWSR1 Immunotherapy in Ewing Sarcoma and DSRCTRabi Hanna · not yet recruiting · Ewing Sarcoma, Desmoplastic Small Round Cell Tumor · principal investigator
- Ph1NCT07194044 · Metastatic Ewing's Trial Testing Schedule Enhancement to Improve OutcomesH. Lee Moffitt Cancer Center and Research Institute · recruiting · Metastatic Ewing Sarcoma · principal investigator
- Ph1NCT05210374 · Disulfiram With Copper Gluconate and Liposomal Doxorubicin in Treatment-Refractory SarcomasCase Comprehensive Cancer Center · recruiting · Relapsed Sarcomas · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 01:24 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 01:24 UTC. The ranking covers the 200 most relevant of 20 PubMed records, and a shared surname and initials can bring in a namesake. All 20 on PubMed
- Phase I (safety) study of autologous tolerogenic dendritic cells in type 1 diabetic patients.Diabetes Care · 2011342 citationsRCR 8.2
- Axitinib plus pembrolizumab in patients with advanced sarcomas including alveolar soft-part sarcoma: a single-centre, single-arm, phase 2 trial.Lancet Oncol · 2019334 citationsRCR 12.1
- Improved quality of life following total pancreatectomy and auto-islet transplantation for chronic pancreatitis.J Gastrointest Surg · 201282 citationsRCR 3.0
- The Trial to Reduce IDDM in the Genetically at Risk (TRIGR) study: recruitment, intervention and follow-up.Diabetologia · 201146 citationsRCR 1.4
- Open-Label, Multicenter, Phase I/II, First-in-Human Trial of TK216: A First-Generation EWS::FLI1 Fusion Protein Antagonist in Ewing Sarcoma.J Clin Oncol · 202438 citationsRCR 4.6
- Augmentation of chimerism in whole organ recipients by simultaneous infusion of donor bone marrow cells.Transplant Proc · 199538 citationsRCR 1.5
- A dose-finding study of temsirolimus and liposomal doxorubicin for patients with recurrent and refractory bone and soft tissue sarcoma.Int J Cancer · 201336 citationsRCR 1.1
- Phase II Study of ONC201 in Neuroendocrine Tumors including Pheochromocytoma-Paraganglioma and Desmoplastic Small Round Cell Tumor.Clin Cancer Res · 202235 citationsRCR 2.3
- 33 citationsRCR 1.2
- Effectiveness of a dance-physiotherapy combined intervention in Parkinson's disease: a randomized controlled pilot trial.Neurol Sci · 202124 citationsRCR 2.4